Accessibility Menu
AptarGroup Stock Quote

AptarGroup (NYSE: ATR)

$118.70
(0.4%)
+0.43
Price as of November 12, 2025, 2:55 p.m. ET

KEY DATA POINTS

Current Price
$118.70
Daily Change
(0.4%) +$0.43
Day's Range
$118.56 - $119.71
Previous Close
$118.27
Open
$119.23
Beta
0.71
Volume
6,207
Average Volume
522,622
Sector
Market Cap
7.8B
Market Cap / Employee
$118.27M
52wk Range
$103.23 - $176.39
Revenue
-
Gross Margin
0.31%
Dividend Yield
1.55%
EPS
$6.24
CAPs Rating
-
Industry
Containers and Packaging

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

AptarGroup Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ATR-32.02%+1.31%+0.26%+3,533%
S&P+14.08%+93.57%+14.12%+1,467%

AptarGroup Company Info

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$961.13M5.7%
Gross Profit$287.85M1.4%
Gross Margin29.95%-1.3%
Market Cap$8.81B-17.2%
Market Cap / Employee$0.65M0.0%
Employees13.5K-2.2%
Net Income$127.83M27.9%
EBITDA$214.33M2.5%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$257.06M-21.0%
Accounts Receivable$812.15M13.7%
Inventory547.312.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$595.23M-32.5%
Short Term Debt$654.57M158.6%

Ratios

Q3 2025YOY Change
Return On Assets8.62%1.1%
Return On Invested Capital8.85%0.5%

Cash Flow

Q3 2025YOY Change
Free Cash Flow$114.29M-29.8%
Operating Free Cash Flow$177.61M-22.5%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Earnings28.3927.1326.9821.42-33.45%
Price to Book4.113.994.073.26-26.50%
Price to Sales2.982.822.902.43-19.90%
Price to Tangible Book Value8.047.707.766.05-32.33%
Price to Free Cash Flow TTM42.2038.6343.0145.5218.41%
Enterprise Value to EBITDA60.5160.4553.1446.35-16.92%
Free Cash Flow Yield2.4%2.6%2.3%2.2%-15.55%
Return on Equity15.7%15.2%15.4%15.8%11.43%
Total Debt$1.09B$1.06B$1.14B$1.25B10.14%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.